Abstract:A great many cardiovascular drugs (CVDs) have the potential to induce adverse reactions in the mouth. The prevalence of such reactions is not known, however, since many are asymptomatic and therefore are believed to go unreported. As more drugs are marketed and the population includes an increasing number of elderly, the number of drug prescriptions is also expected to increase. Accordingly, it can be predicted that the occurrence of adverse drug reactions (ADRs), including the oral ones (ODRs), will continue to increase. ODRs affect the oral mucous membrane, saliva production, and taste. The pathogenesis of these reactions, especially the mucosal ones, is largely unknown and appears to involve complex interactions among the drug in question, other medications, the patient's underlying disease, genetics, and life-style factors. Along this line, there is a growing interest in the association between pharmacogenetic polymorphism and ADRs. Research focusing on polymorphism of the cytochrome P450 system (CYPs) has become increasingly important and has highlighted the intra- and inter-individual responses to drug exposure. This system has recently been suggested to be an underlying candidate regarding the pathogenesis of ADRs in the oral mucous membrane. This review focuses on those CVDs reported to induce ODRs. In addition, it will provide data on specific drugs or drug classes, and outline and discuss recent research on possible mechanisms linking ADRs to drug metabolism patterns. Abbreviations used will be as follows: ACEI, ACE inhibitor; ADR, adverse drug reaction; ANA, antinuclear antigen; ARB, angiotensin II receptor blocker; BAB, beta-adrenergic blocker; CCB, calcium-channel blocker; CDR, cutaneous drug reaction; CVD, cardiovascular drug; CYP, cytochrome P450 enzyme; EM, erythema multiforme; FDE, fixed drug eruption; I, inhibitor of CYP isoform activity; HMG-CoA, hydroxymethyl-glutaryl coenzyme A; NAT, N-acetyltransferase; ODR, oral drug reaction; RDM, reactive drug metabolite; S, substrate for CYP isoform; SJS, Stevens-Johnson syndrome; SLE, systemic lupus erythematosus; and TEN, toxic epidermal necrolysis.

Association between cardiocerebrovascular drugs and adverse drug reactions

Analysis of Association between Adverse Drug Reactions Induced by Cardiovascular and Cerebrovascular Drugs and Patients

ADRs monitoring and analysis of cardiovascular drugs

Cluster Analysis on The Adverse Drug Reactions Caused by Medication Used for Cardiovascular Disease and Cerebrovascular Disease According to The Varieties of Drugs

Adverse drug reaction reports in department of cardiology of a 3 A hospital:an analysis of 572 cases

Analysis of 84 Cases of Adverse Reactions Induced by Voriconazole

Pharmacovigilance of cutaneous adverse drug reactions in associations with drugs and medical conditions: a retrospective study of hospitalized patients

Analysis of Adverse Drug Reactions in 468 Cases

ORAL ADVERSE DRUG REACTIONS TO CARDIOVASCULAR DRUGS

Analysis of 136 ADRs Induced by Chinese Patent Medicine

Carbapenem Antibacterial Drugs Induced Adverse Drug Reaction

Study on 990 Cases of Adverse Drug Reaction

The Characteristics and Regularities of Cardiac Adverse Drug Reactions Induced by Chinese Materia Medica: A Bibliometric Research and Association Rules Analysis.

ADR Case Reports:Analysis of 810 Cases

Data mining techniques for detecting signals of adverse drug reaction of cardiac therapy drugs based on Jinan adverse event reporting system database: a retrospective study

Adverse drug reactions of non-statin antihyperlipidaemic drugs in China from 1989 to 2019: a national database analysis

Analysis of the Adverse Drug Reactions Reports of 139 Cases

Analysis of 937 adverse drug reaction cases

Brief Analysis of Adverse Drug Reaction Information Bulletin Issued by National Center for Adverse Drug Reaction Monitoring

Adverse Drug Reactions Induced by Anti-infectives:Analysis of 657 Cases

2008-2011 Adverse Drug Reaction Analysis of 490 Cases in Huadong Hospital